⌘K

Login Start Free

Home/Filings/4/0001144204-12-065647

4//SEC Filing

Blachman Amir 4

Accession 0001144204-12-065647

CIK 0001420030other

View on SEC.gov Company Profile

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 7:34 PM ET

Size

12.1 KB

Accession

0001144204-12-065647

Insider Transaction Report

Form 4

Period: 2012-11-12

Targeted Medical Pharma, Inc.NONE

VP of Strategy and Operations

Transactions

Exercise/Conversion
Common Stock
2012-11-12$3.38/sh+2,396$8,098→ 2,396 total
Tax Payment
Common Stock
2012-11-12$5.00/sh−54,986$274,930→ 26,354 total
Exercise/Conversion
Options to Purchase Common Stock
2012-11-12−7,395→ 0 total
Exercise: $3.38From: 2010-05-16Exp: 2020-05-16→ Common Stock (7,395 underlying)
Exercise/Conversion
Options to Purchase Common Stock
2012-11-12−73,945→ 0 total
Exercise: $3.38Exp: 2020-07-28→ Common Stock (73,945 underlying)
Exercise/Conversion
Common Stock
2012-11-12$3.38/sh+23,958$80,978→ 23,958 total

Footnotes (1)

[F1]These options vested on a monthly basis in equal installments over a two-year period beginning 07/28/2012

Documents

1 file

4
v329485_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Targeted Medical Pharma, Inc.

CIK 0001420030

Entity typeother

Related Parties

1

filerCIK 0001509562

Filing Metadata

Form type: 4
Filed: Nov 28, 7:00 PM ET
Accepted: Nov 29, 7:34 PM ET
Size: 12.1 KB

View on SEC.gov